Page 36 - 84_01

The nucleotide vesicular transporter (VNUT). Relevance in neural and neuroendocrine tissues. New pharmacological perspectives
93. Bankston LA, Guidotti G. Characterization of ATP
transport into chromaffin granule ghosts. Synergy of
ATP and serotonin accumulation in chromaffin
granule ghosts. J Biol Chem 1996; 271: 17132-8.
94. Zimmermann H. Turnover of adenine nucleotides in
cholinergic synaptic vesicles of the Torpedo electric
organ. Neuroscience 1978; 3: 827-36.
95. Luqmani YA. Nucleotide uptake by isolated
cholinergic synaptic vesicles: evidence for a carrier of
adenosine 5'-triphosphate. Neuroscience 1981; 6:
1011-21.
96. Gualix J, Pintor J, Miras-Portugal MT.
Characterization of nucleotide transport into rat brain
synaptic vesicles. J Neurochem 1999; 73: 1098-104.
97. Roseth S, Fykse EM, Fonnum F. Uptake of L-
glutamate into rat brain synaptic vesicles: effect of
inhibitors that bind specifically to the glutamate
transporter. J Neurochem 1995; 65: 96-103.
98. Neet KE, Ainslie GR, Jr. Hysteretic enzymes.
Methods Enzymol 1980; 64: 192-226.
99. Casillas T, Delicado EG, Garcia-Carmona F, et al.
Kinetic and allosteric cooperativity in L-adenosine
transport in chromaffin cells. A mnemonical
transporter. Biochemistry 1993; 32: 14203-9.
100.McLennan AG. Dinucleoside polyphosphates-friend
or foe? Pharmacol Ther 2000; 87: 73-89.
101.Miyaji T, Sawada K, Omote H, et al. Divalent cation
transport by vesicular nucleotide transporter. J Biol
Chem 2011; 286: 42881-7.
102.Gropp T, Brustovetsky N, Klingenberg M, et al.
Kinetics of electrogenic transport by the ADP/ATP
carrier. Biophys J 1999; 77: 714-26.
103.Austin J, Aprille JR. Carboxyatractyloside-insensitive
influx and efflux of adenine nucleotides in rat liver
mitochondria. J Biol Chem 1984; 259: 154-60.
104.Montezinho LP, Fonseca CP, Geraldes CF, et al.
Quantification and localization of intracellular free mg
in bovine chromaffin cells. Met Based Drugs 2002; 9:
69-80.
105.Gunther T. Concentration, compartmentation and
metabolic function of intracellular free Mg2+. Magnes
Res 2006; 19: 225-36.
106.Kato Y, Hiasa M, Ichikawa R, et al. Identification of a
vesicular ATP release inhibitor for the treatment of
neuropathic and inflammatory pain. Proc Natl Acad
Sci U S A 2017.
107.Kato Y, Omote H, Miyaji T. Inhibitors of ATP release
inhibit vesicular nucleotide transporter. Biol Pharm
Bull 2013; 36: 1688-91.
108.Martin CA, Krantz DE. Drosophila melanogaster as a
genetic model system to study neurotransmitter
transporters. Neurochem Int 2014; 73: 71-88.
109.Hobert O. The neuronal genome of Caenorhabditis
elegans. WormBook 2013: 1-106.
110.Sesma JI, Kreda SM, Okada SF, et al. Vesicular
nucleotide transporter regulates the nucleotide content
@Real Academia Nacional de Farmacia. Spain
in airway epithelial mucin granules. Am J Physiol Cell
Physiol 2013; 304: C976-84.
111.Jung SK, Morimoto R, Otsuka M, et al.
Transmembrane topology of vesicular glutamate
transporter 2. Biol Pharm Bull 2006; 29: 547-9.
112.Foss SM, Li H, Santos MS, et al. Multiple dileucine-
like motifs direct VGLUT1 trafficking. J Neurosci
2013; 33: 10647-60.
113.Juge N, Yoshida Y, Yatsushiro S, et al. Vesicular
glutamate transporter contains two independent
transport machineries. J Biol Chem 2006; 281: 39499-
506.
114.Almqvist J, Huang Y, Laaksonen A, et al. Docking
and homology modeling explain inhibition of the
human vesicular glutamate transporters. Protein Sci
2007; 16: 1819-29.
115.Iharada M, Miyaji T, Fujimoto T, et al. Type 1
sodium-dependent phosphate transporter (SLC17A1
Protein) is a Cl(-)-dependent urate exporter. J Biol
Chem 2010; 285: 26107-13.
116.Sakamoto S, Miyaji T, Hiasa M, et al. Impairment of
vesicular ATP release affects glucose metabolism and
increases insulin sensitivity. Sci Rep 2014; 4: 6689.
117.Nakagomi H, Yoshiyama M, Mochizuki T, et al.
Urothelial ATP exocytosis: regulation of bladder
compliance in the urine storage phase. Sci Rep 2016;
6: 29761.
118.Masuda T, Ozono Y, Mikuriya S, et al. Dorsal horn
neurons release extracellular ATP in a VNUT-
dependent manner that underlies neuropathic pain. Nat
Commun 2016; 7: 12529.
119.Larsson M, Sawada K, Morland C, et al. Functional
and anatomical identification of a vesicular transporter
mediating neuronal ATP release. Cereb Cortex 2012;
22: 1203-14.
120.Ho T, Jobling AI, Greferath U, et al. Vesicular
expression and release of ATP from dopaminergic
neurons of the mouse retina and midbrain. Front Cell
Neurosci 2015; 9: 389.
121.Wise RA. Dopamine and reward: the anhedonia
hypothesis 30 years on. Neurotox Res 2008; 14: 169-
83.
122.Joshua M, Adler A, Bergman H. The dynamics of
dopamine in control of motor behavior. Curr Opin
Neurobiol 2009; 19: 615-20.
123.Schultz W. Updating dopamine reward signals. Curr
Opin Neurobiol 2013; 23: 229-38.
124.Cachope R, Cheer JF. Local control of striatal
dopamine release. Front Behav Neurosci 2014; 8: 188.
125.Benazzouz A, Mamad O, Abedi P, et al. Involvement
of dopamine loss in extrastriatal basal ganglia nuclei
in the pathophysiology of Parkinson's disease. Front
Aging Neurosci 2014; 6: 87.
126.Diez-Zaera M, Diaz-Hernandez JI, Hernandez-
Alvarez E, et al. Tissue-nonspecific alkaline
phosphatase promotes axonal growth of hippocampal
37